Conference call to discuss positive topline results from pivotal phase 3 clinical trial of Oral Lefamulin held on May 21 at 8:30 am. Weblink: https://investors.nabriva.com/events/event-details/nabriva-therapeutics-leap-2-phase-3-trial-topline-results-conference-call
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.